Janus Henderson Group PLC Keros Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $187 Billion
- Q3 2024
A detailed history of Janus Henderson Group PLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 92,110 shares of KROS stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92,110
Previous 14,307
543.81%
Holding current value
$1 Million
Previous $653,000
718.99%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding KROS
# of Institutions
172Shares Held
29.8MCall Options Held
76.8KPut Options Held
9K-
Black Rock Inc. New York, NY2.51MShares$27.3 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.9MShares$20.6 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$20.2 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.52MShares$16.5 Million7.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.51MShares$16.4 Million0.01% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $280M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...